Brief: Genetic Technologies’ Covid-19 Risk Test Now Available In Us Through Partnership With Infinity Biologix
01/06/2021 14:05
June 1 (Reuters) - Genetic Technologies Ltd GTG.AX :
* GENETIC TECHNOLOGIES’ COVID-19 RISK TEST NOW AVAILABLE IN
US
THROUGH PARTNERSHIP WITH INFINITY BIOLOGIX
Source text for Eikon: ID:nGNX8x3k2L
Further company coverage: GTG.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genetic Technologies
See all newsBrief: ASX Says Genetic Technologies To Be Removed From Official List
Brief: Genetic Technologies Announces Termination Of ADR Facility
Brief: Genetic Technologies To Not Proceed With Ellerfield Wealth Acquisition
Brief: Genetic Technologies Says Binding Term Sheets Executed For Strategic Acquisitions
Brief: Genetic Technologies Appointed Michael Walker As Executive Chairman